|
Getting your Trinity Audio player ready...
|
Synergy CHC Corp. (NASDAQ: SNYR), a consumer health and wellness brand powerhouse, reported 30% year-over-year EPS growth and its ninth straight profitable quarter. EBITDA margin jumped to 24.1%, fueled by cost discipline and strong brand traction for FOCUSfactor and Flat Tummy.
While quarterly revenue totaled $8.2M (vs. $9.4M YoY), net income climbed to $876K. The company is preparing for international expansion and ramping up its GLP-1 support product line, targeting high-demand wellness trends.
CEO Jack Ross confirmed Synergy has secured term sheets to refinance debt through 2029, aiming to boost free cash flow and accelerate growth. With a strategic roadmap in place, SNYR is positioned for breakout momentum in 2025. Read Entire Seeking Alpha News Article Now!
Other Stocks Under $2 to Watch: Amesite Inc. (NASDAQ: AMST), Inozyme Pharma Inc. (NASDAQ: INZY), Treasure Global Inc. (NASDAQ: TGL), and Peraso Inc. (NASDAQ: PRSO). For investors focused on under-the-radar opportunities, these stocks under $2 are rapidly gaining attention along with Synergy CHC Corp. (NASDAQ: SNYR). Each company is making headlines through innovative tech, biotech breakthroughs, and strategic partnerships—positioning them as high-upside candidates in a market hungry for momentum plays.